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Sodium
Butyrate Induces Histone Hyperacetylation and
Differentiation
of Murine Embryonal Carcinoma Cells
ABSTRACT
￿
Cells
from embryonal carcinoma (EC) lines 6050AJ and PCC4
.aza1
R differentiate
in
response to treatment with sodium butyrate as well as retinoic acid (RA) or hexamethyl-
enebisacetamide
(HMBA)
.
Murine 6050AJ EC cells exposed to sodium butyrate possess
hyperacetylated
forms of histones H4 and altered forms of histones H2a and H2b, whereas
histones
from cells treated with other inducers appear to be unaffected
.
These results might
indicate
that the mechanism by which sodium butyrate promotes differentiation of EC cells is
different
from the ways in which RA and HMBA act
.
Differentiation-defective PCC4(RA)-1 EC
cells
fail to respond to RA, presumably because they possess minimal amounts of active
binding
protein for RA (cRABP)
.
Sodium butyrate treatment of these cells results in only a
modest
level of differentiation
.
On the other hand, exposure to sodium butyrate plus RA leads
to
extensive differentiation
.
As is the case with 6050AJ cells, PCC4(RA)-1 cells treated with
sodium
butyrate also contain hyperacetylated histones
.
Furthermore, these cells now possess
high
levels of cRABP
.
The latter observations suggest that sodium butyrate has the ability to
reactivate
a silent cRABP gene in PCC4(RA)-1 cells and thereby lead to extensive differentiation
via
the retinoid pathway when RA is added
.
Regions
within the chromosome that are beingactively tran-
scribed
appear to undergo alterations in chromatin structure
(1-5).
These alterations might be necessary to facilitate acces-
sibility
of the nucleosomal DNA to RNA polymerase binding
or
function (6-8)
.
Structural changes have been variously
ascribed
to differential interactions of nonhistone chromo-
somal
proteins with mononucleosomes (9, 10)
;
alterations in
methylation
of specific regions of the DNA (11, 12)
;
and
postiranslational
modifications of core-particle histories due
to
phosphorylation or hyperacetylation (6, 8, 13)
.
The accu-
mulation
of hyperacetylated core particle histories is one of
many
changes occurring during rapid cell growth, maturation,
and
cell differentiation
.
When cell cultures are exposed to
millimolar
concentrations of sodium butyrate they accumu-
late
hyperacetylated core-particle histones, notably histories
H3
and H4, due to the inhibition of activity of histone
deacetylase(s)
(14, 15)
.
Such treatments can lead to the initi-
ation
of new gene expression resulting in, for example, the
production
of alphafetoprotein in rat hepatoma cells (16),
induction
of thymidine kinase in thymidine kinase-minus
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CHO
cells(17), and the differentiation of murine erythroleu-
kemia
and human neuroblastoma cells (18, 19)
.
Embryonal
carcinoma (EC)' cell lines have proven to be
useful
in studies of physical and chemical stimuli leading to
differentiation
(e
.g.
20, 21)
.
Retinoic acid (RA) and hexa-
methylenebisacetamide
(HMBA) are particularly effective
promoters
of EC cell differentiation (21-23)
.
The induction
of
EC cell differentiation by the former compound appears to
be
mediated by its interaction with a specific cellular binding
protein
(cRABP) (24, 25)
.
HMBAdoes not compete with RA
for
cRABP sites, although evidence has been presented to
suggest
that its effectiveness is also related in some way to
cRABP
function
:
mutant EC linesthat lack detectable levels
of
cRABP fail to differentiate in response to either RA or
HMBA
(25, 26)
.
Finally, it has been proposed that the RA-
cRABP
complex acts by translocating to the nucleus and
'Abbreviations
used in this paper
:
EC, embryonal carcinoma
;
HMBA,
hexamethylenebisacetamide
;
RA, retinoic acid
;
and SSEA-
1,
stage-specific embryonic antigen
.
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.00influencing gene expression by interaction with chromatin
(24) . The alterations in the pattern of gene expression would
presumably be specific, involving suppression of genes char-
acteristic ofundifferentiated cells and activation ofother genes
that lead to a differentiated phenotype .
To determine whether sodium butyrate, an agent that ap-
pears to cause random gene activation (27), is capable of
promoting differentiation ofEC cells,we added this chemical
to three cultured EC lines and compared its effects with those
ofRA and HMBA . One of the cell lines studied lacks cRABP
activity and is defective for differentiation. The results indicate
that sodium butyrate can cause dramatic alterations in the
phenotype of EC cells and suggest that the differentiation-
defective mutant under study possesses one or more intact
cRABP structural gene(s) reactivated by sodium butyrate .
MATERIALS AND METHODS
Cell Lines and Culture Techniques : Sources, derivations, and
properties of EC cell lines 6050AJ, PCC4.aza1R, and PCC4(RA)- 1 have been
described previously (20, 25) . Cells were grown at 37°C (5% C0 2 in air) in
Dulbecco-modified Eagle's medium supplemented with 10% fetal calfserum,
antibiotics, and extra glucose and glutamine (20) . Cells were exposed as indi-
cated to 10-6M RA, 3 mM HMBA, 1-3mM sodium butyrate ora combination
of RA and sodium butyrate for up to 10 d. Procedures involving RA were
carried out in a room in which light of wavelengths<550 nm was filtered out .
Detection of SSEA-I Antigen:
￿
The presence or absence of cell
surface stage-specific embryonic antigen (SSEA-1), whose expression is char-
acteristic of undifferentiated EC cells (28), was determined by immunofluores-
cence analysis: briefly, after culture for 5 d in plastic tissue culture dishes
containing medium with or without chemical effectors, cells were rinsed with
Hank's balanced salt solution and fixed with cold methanol for 10 min . The
fixed cellswere rinsed with phosphate-buffered saline and incubatedfor 45 min
with a monoclonal antibody raised against SSEA-1 (28) and diluted 1:300. The
cells were washed with phosphate-buffered saline and exposed to a fluorescein-
conjugated secondary antibody (Litton Bionetics, Frederick, MD ; 1:20) for 45
min . After a further wash, the stained cells were evaluated with a Leitz
Orthoplan microscope equipped with Ploem illumination.
Assays for Plasminogen Activator:
￿
Cellswereassayed for secretion
ofplasminogen activator by the fibrin-agar overlay assay as described by Beets
et al . (29). Sparse cultures wereincubated under the overlay for 6h . Fibrinolytic
zones were identified and counted following Coomassie Brilliant Blue staining.
A total of 300 single cells were scored for each experimental condition .
Isolation of Histones :
￿
Histones were isolated by a modification of
the procedures of Vidali et al . (30) and Candido et al . (31) . Briefly, monolayers
were disrupted by a brieftrypsinization and cells were pelleted and washed in
phosphate-buffered saline . The cell pellet was resuspended in reticulocyte
suspension buffer (10 mM Tris pH 7 .4, 10 mM NaCl and 3 MM M902)
containing 0.1% phenylmethylsulfonylfluoride and washed twice. Cells were
then lysed in reticulocyte suspension buffer containing 0.5% Nonidet P-40 for
5 min at 0°C . After centrifugation at 8,000 g the supernate was made 0.2 N in
H 2SO .and mixedgently for 15 min at 0°C . Acid-soluble proteins were collected
following centrifugation at 12,000 g for 10 min. The histones in the supernate
were precipitated overnight in 10 vol cold acetone at -20°C . After sedimenta-
tion at 3,000 g, histories were dissolved in 0 .1 M acetic acid, dialyzed .1 h
against 0.1 M acetic acid, and lyophilized . Proteindeterminations were by Bio-
Rad protein assay (Bio-Rad Laboratories, Richmond, CA) (32).
Acid-Urea Polyacrylamide Analysis of Histones : Histories
were analyzed by acid-urea gel electrophoresis on 15% acrylamide : 0.8% bis-
acrylamide slab gels containing 6.25M urea (33) . 30 t<g oftotal histones in 2 .5
M urea/5% acetic acid buffer were electrophoresed 24 h at 200 V with cooling .
Gels were stained 1 h in 7% acetic acid containing 1% Amido black and I h in
0 .1 % Coomassie Blue in 7% acetic acid:5% methanol . Gels were destained in
7% acetic acid:5% methanol.
Measurement of Cellular Retinoic Acid-binding Pro-
tein :
￿
cRABP activity was measured as detailed by Schindler et al. (25) and
Sherman et al . (34) : cytosolic extracts were prepared by disrupting cells and
collecting the supernates after high speed centrifugation . Extracts were incu-
bated with ['HJRA (2 .5 x 10 -° M ; 30 Ci/mM) plus or minus a 200-fold excess
of unlabeled RA at 0°C for 4 h ; unbound RA was subsequently removed with
charcoal-coated dextran . Reaction mixtures were then subjected to sucrose
density gradient centrifugation (25) or Sephadex G25 chromatography (34) and
MCCUE
fractions were collected and counted . Specific binding activity is calculated as
the difference in the labeled RA associated with the excluded volume of the
Sephadex column or the 2S region of the gradient in the absence and presence
ofexcess unlabeled RA .
RESULTS
Effects of Sodium Butyrate on EC
Cell Morphology
Under normal culture conditions, 6050AJ and
PCC4.aza 1R EC cells are characteristically small and round
with scant cytoplasm and large nuclei containing prominent
nucleoli (e.g., Figs . IA and 2A). After exposure to 10-6 M
RA or 3 mM HMBA, cells from lines 6050AJ and
PCC4.aza1R assume a differentiated phenotype, i.e., flat,
polygonal cells with increased cytoplasmic volume and a
dispersed chromatin pattern (Fig. 1, B and C, and references
25, 26) . Treatment of the same cells with 1 mM sodium
butyrate induces similar morphological differentiation of a
substantial fraction of the cells (Figs . 1 D and 2B) without
evidence of toxicity or notable effects on proliferation (Fig.
3A) . As Fig. 2C illustrates, PCC4.aza1R cells with altered
morphology retained this phenotype for at least 72 h after
removal of sodium butyrate .
Under standard culture conditions, PCC4(RA)- 1 cells ap-
pear small, rounded and birefringent (Fig . 4A ; references 25,
26) . After exposure to 1mM sodium butyrate, the cells flatten
somewhat and acquire a more typical EC morphology (Fig.
4B) . The proliferation rate is only slightly affected (Fig. 3B) .
There is no sign of cells with a non-EC phenotype . When
PCC4(RA)- 1 cells are exposed to 3 mM sodium butyrate,
extensive toxicity is observed. However, if cells are cultured
for 1 d in I mM sodium butyrate before exposure to the
inducer at 3 mM, some toxicity is observed but there is no
net loss of cells (Fig . 3B ; parental PCC4.aza lR cells behave
similarly [Fig. 3A]) . Of the surviving PCC4(RA)- 1 cells,
10% possess a fibroblastic morphology . When 10-6 M RA
is added concomitantly with the sodium butyrate, there is no
further effect upon viability (Fig . 3B) but many more of the
treatedPCC4(RA)- 1 cells assume an altered morphology (Fig.
FIGURE 1
￿
Changes in morphology of 6050AJ EC cells in response
to RA, HMBA, and sodium butyrate . (A) cells in control medium ;
(B) cells exposed to 3 mM HMBA for 5 d ; (C) cells exposed to 10-6
M RA for 5 d ; (D) cells exposed to 1 mM sodium butyrate for 5 d .
All figures are phase-contrast micrographs . Bar, 50Am .
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￿
Effects of sodium butyrate upon PCC4.aza1R cells. (A)
PCC4.aza1 R cells in control medium; (B) PCC4.aza1 R cells exposed
to 1 mM sodium butyrate for 4 d ; (C) PCC4.aza1 R cells after 5 d of
exposure to 1 mM sodium butyrate followed by 3 d in the absence
of this compound . Bar, 50 jum .
4C) . In fact, within 10 d of culture, about halfofthe cells are
non-EC-like in appearance with the monolayer containing
discrete areas of both fibroblastic and epithelioid cells (Fig .
5) . It is unlikely that the latter result is due to selection of a
minor population of differentiated cells in the original
PCC4(RA)- 1 cultures because such cells have never been
observed in these cultures under other conditions . Also, cell
numbers are similar in cultures treated with sodium butyrate
plus or minus RA, whereas the proportion of non-EC cells is
much greater in the former case .
Analysis of Differentiation by Loss of SSEA-I
Analysis of undifferentiated cells from lines 6050AJ,
PCC4.aza1R and PCC4(RA)- 1 by indirect immunofluores-
cence demonstrated the presence of SSEA-1 on almost all
cells (e.g., Fig . 6, B and F) . Expression of SSEA-1 is lost by
6050AJ and PCC4.aza 1R cells after exposure to sodium bu-
tyrate (Fig. 6D ; and reference 26), as is observed when these
604
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cells are treated with RA or HMBA (26). PCC4(RA)- 1 cells
retain SSEA-1 when treated with RA (Fig . 6F) or HMBA
(26). In the presence of sodium butyrate, some cells lose
reactivity to SSEA-1 antibody (not shown). After treatment
with sodium butyrate plus RA, the population that loses
reactivity is substantial and the remaining fluorescence does
not appear to associate characteristically with cell surfaces
(Fig . 6H) .
Production ofPlasminogen Activator
Measurement of plasminogen activator secretion by the
fibrin-agar overlay assay demonstrated low basal levels of
secretion in 6050AJ, PCC4.azalR, and PCC4(RA)- 1 cells
when maintained in the absence of inducers . Exposure to
10-6M RA causes a marked increase in the number of lysis
zones surrounding single 6050AJ and PCC4.aza1R cells but
has little effect on PCC4(RA)- 1 mutant cells (Table I) . In the
presence of sodium butyrate 6050AJ and PCC4.aza1R cells
also show large increases in the number of plasminogen
activator-secreting cells, although the values are not as great
as those seen after treatment with RA . Plasminogen activator
secretion by PCC4(RA)- 1 cells is essentially unaffected by
exposure to sodium butyrate. However, when these cells are
treated with sodium butyrate plusRA, there is a large increase
in the number of secreting cells (Table I) .
Effects of RA, HMBA, and Sodium Butyrate on
Histone Profiles
Upon PAGE, total histones isolated from untreated 6050AJ
or PCC4(RA)- 1 cells exhibit a distinct distribution ofhistone
subspecies . Three histone H3 subspecies (non-, mono-, and
diacetylated forms denoted H3o, H3,, and H32, respectively)
and three forms of histone H4 (H4o, H4,, H42 ) are observed
m
z
Û
FIGURE 3 Effects of so-
dium butyrate upon
growth of PCC4.aza1 R and
PCC4(RA)- 1 cells . Cells are
seeded at 2 x 105/60-mm
tissue culture dish . On the
day after seeding (first ar-
rows), some of the cells
were maintained in control
medium (p), whereas
others received 1 mM bu-
tyrate (0) . 1 d later (second
arrows) cells from some of
the latter dishes were ex-
posed to 3 mM butyrate
alone (0) or together with
10-6 M RA (p). Culture
media in all dishes were
changed every 2 d . Cells
were removed from dishes
with trypsín-EDTA solu-
tion and counted with a
hemocytometer . Values
shown are averaged from
tripli( ate determinations .
(A) ''CC4.aza1R cells ; (B)
PC(.4(RA)- 1 cells .FIGURE 4
￿
Effects of sodium butyrate upon PCC4(RA)- 1 cells . (A)
PCC4(RA)- 1 cells in control medium ; (B) PCC4(RA)- 1 cells following
4 d of exposure to 1 mM sodium butyrate; (C) PCC4(RA)- 1 cells
after treatment for 1 d with 1 mM sodium butyrate and 3 d with 3
mM sodium butyrate plus 10-6 M RA . Bar, 50 /Am .
(Fig . 7, A and B) . Differentiation of 6050AJ cells induced by
either RA or HMBA does not notably alter the acetylation
patterns . The only obvious change observed is a reduction in
theamount of histone H4Z (Fig. 7A, lanes 3 and 4) . However,
upon induction of differentiation of these EC cells with so-
dium butyrate, there is a marked increase in histone subspe-
cies H4 Z , H43 , and H44 with a concomitant decrease in the
amounts of histone H4o and H4, (Fig. 7A, lane 2) . There is
also an increase in subspecies of histones H2a and H2b .
Untreated PCC4(RA)- 1 cells and PCC4(RA)- 1 cells exposed
to either 10-6M RA or 3mM HMBA yield identical comple-
ments oftotal histones (Fig . 7 B) and the patterns are similar
to those obtained with nonmutant EC cells . As Fig. 7B
illustrates, histones isolated from sodium butyrate-treated
PCC4(RA)-1 cells also exhibit an accumulation of multi-
acetylated forms ofhistone H4 (H4 Z-H44), as well as multiple
forms in the histone H2a/H2b region of the gel .
Effects of Sodium Butyrate on Cellular RA-
binding Protein in Mutant Cells
In the absence oftreatment with inducers ofdifferentiation,
6050AJ (35) and PCC4.aza1R (35 ; Table II) cells possess
readily detectable levels ofcRABP, whereas values for differ-
entiation-defective PCC4(RA)-1 cells are at or barely above
background (25 ; Fig. 8B and Table II). Levels ofcRABP often
change when EC cells are induced to differentiate ; the values
reached appear to reflect the nature of the differentiated
progeny (35). When PCC4.aza1R cells are treated for several
days with RA, cRABP values rise about threefold (Table II) .
A more modest increase is observed following exposure ofthe
cells to sodium butyrate .
The very low levels ofcRABP activity in PCC4(RA)- 1 cells
do not change following treatment ofthe cells withRA (Table
II) . However, when PCC4(RA)- 1 cells are exposed to sodium
butyrate with or without RA, and are tested for the presence
of binding protein, cytosolic extracts show levels of binding
activity which are elevated more than 10-fold (Table II) .
Binding of['H]RA can be dramatically reduced with an excess
ofunlabeledRA and resides in the 2S region following sucrose
gradient sedimentation (Fig . 8A) . In these respects, the activity
resembles the cRABP activity found in other EC cells (24,
25) .
DISCUSSION
After treatment with sodium butyrate, 6050AJ and
PCC4.aza1R cells undergo dramatic morphological altera-
tions, secrete markedly increased amounts of plasminogen
activator and lose SSEA-1 surface antigen . Taken together,
FIGURE 5 Long-term effects of sodium butyrate plus RA upon
PCC4(RA)- 1 cells . Cells were exposed to 1 mM sodium butyrate
for 1 d and subsequently to 3 mM sodium butyrate plus 10-6 M RA
for 9 d . (A) cluster of cells with a fibroblastic morphology ; (B) cluster
of cells with an epitheloid morphology .
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￿
Immunoreactivity of 6050AJ and PCC4(RA)-1 EC cells
with antibody to the SSEA-1 antigen . Phase-contrast micrographs
are shown in A, C, E, and G; corresponding immunofluorescence
profiles are shown in B, D, F, and H. (A and B) 6050AJ cells in the
absence of inducers ; (C and D) 6050AJ cells after 5 d of treatment
with 1 mM sodium butyrate; (E and F) PCC4(RA)-1 cells in the
presence of 10-6 M RA; (G and H) PCC4(RA)-1 cells after 1 d of
exposure to 1 mM sodium butyrate, then 4 dof combined treatment
with 3mM sodium butyrate and 10-6MRA .
these phenotypic alterations demonstrate clearly that differ-
entiation has occurred (20, 25, 26, 28, 34). Histone H4 from
sodium butyrate-treated EC cells is hyperacetylated as has
been observed with other cells (13). Multiple forms ofhistones
H2a and/or H2b are also observed. These might represent
acetylated subspecies as well, although it is possible with these
histone types that the variation is due to phosphorylation (6,
31). As has been suggested previously (1, 6), resultant modi-
fications at the nucleosome level might be partially or fully
responsible for the alterations in gene expression that yield
the observed phenotypic changes (18, 19) . If so, then the
mechanism by which butyrate promotes differentiation ofEC
cells is different from the one(s) operative withRA orHMBA
since these agents did not induce alterations in histone profiles
in our studies .
In a previous report (23) it was claimed that F9 EC cells
are unresponsive to sodium butyrate (concentration unspeci-
fied) . In that study and others, dibutyryl cAMP, when added
along with RA, was shown to enhance the phenotypic differ-
ences between EC cells and the ultimate differentiated deriv-
atives (23, 36-39) . However, the enhancing effect was presum-
ably due to the cAMP rather than the butyrate moiety since
606
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agents such as cholera toxin elicit the same response (23) . It
remains to be determined by a systematic analysis whether
F9 and other EC cells not used in the present investigation
are responsive or unresponsive to sodium butyrate.
In various studies involving new gene expression in the
presence of sodium butyrate, the effects appeared to be re-
versed when the chemical was removed (19, 27) . Our prelim-
inary observations with PCC4.aza 1R cells (see Fig. 2 C) sug-
gest that the described effects of butyrate upon these cells is
irreversible . This is consistent with the view that butyrate has
triggered the permanent differentiation ofEC cells rather than
some transient alteration.
Three notable points emerge from the response of the
differentiation-defective cell line PCC4(RA)- 1 to sodium bu-
tyrate : (a) these cells are less responsive to the inductive effects
of sodium butyrate than the parental line (PCC4.azaIR) and
a second, unrelated EC line (6050AJ) ; (b) although RA fails
to induce differentiation of PCC4(RA)- 1 cells and sodium
butyrate alone has only a modest effect, the combination of
sodium butyrate plus RA promotes extensive differentiation ;
and (c) although PCC4(RA)- 1 cells possess little, if any,
detectablecRABP activity, butyrate-treated cells possess high
levels of cRABP . The large increase of cRABP activity in
PCC4(RA)- I cells is unlikely to be due only to differentiated
cells formed in these cultures because activity levels are similar
whether cells are treated with butyrate alone (in which case
there is little differentiation) or with butyrate plus RA (a
condition promoting substantial differentiation) . Two possi-
bilities are suggested by these observations. The first is that
the paucity ofcRABP activity in PCC4(RA)- 1 cells is not due
to structural mutations in the cRABP genes but rather due to
a trans-acting regulatory block which can be reversed by
butyrate . Alternatively, assuming that the cRABP gene is not
X-linked, it is conceivable that in PCC4(RA)-1 cells, one of
the two genes for cRABP is mutated whereas the homolog is
intact but epigenetically silenced (see reference 17). Sodium
butyrate treatment might reactivate the lattercRABP gene by
altering chromatin structure . Whichever alternative is correct,
our results suggest that sodium butyrate restores the ability of
PCC4(RA)- 1 cells to differentiate by reestablishing the reti-
noid-cRABP pathway ; thus, a maximum effect is seen only
when RA is added along with the sodium butyrate .
Finally, the fact that nonmutagenized cells are more re-
sponsive than PCC4(RA)-1 cells to butyrate alone might
indicate that alternate pathways are potentially operative in
TABLE I
Plasminogen Activator Secretion by EC Cells in theAbsence
and Presence of RA andSodium Butyrate*
% Positive cells
* The assay was performed on sparsely seeded cultures using the fibrin-agar
overlay procedure . Cells were exposed to the chemical effectors for 2 d
and then overlaid with the assay reagents . The cultures were scored for the
presence of lysis zones after 6.5 h . Percentages are based upon counts of
300 single cells for each treatment .
s RA was used at a concentration of 10-6M.
*Sodium butyrate was used at a concentration of 1 mM for 6050A) and
PCC4.aza1R cells and at 3 mM (after 1 d at 1 mM) for PCC4(RA)-7 cells .
t Not done .
Cell line Untreated RA=
Sodium bu-
tyrates
RA + Sodium
butyrate
6050AI 5 51 37 NDI
PCC4.aza1R 1 63 23 ND
PCC4(RA)-1 2 5 3 27FIGURE 8
￿
Sucrose density gradient analysis of RA binding by cy-
tosolic extracts of PCC4(RA)- 1 cells treated with inducers of differ-
entiation . Extracts were prepared, incubated with [ 3H]RA alone (p)
or together with a 200-fold excess of unlabeled R (9) and analyzed
for cRABP activity by centrifugation as described in Materials and
Methods . There extracts were obtained from cells treated either
with (A) 1 mM sodium butyrate for 10 d or with (B) 10-6 M RA for
8 d (followed by culture in the absence of RA for 2 d to diminish
the intracellular concentration of unlabeled RA) . T and B refer to
the top and bottom of the gradient, respectively . The sedimentation
coefficient of the peak in A is approximately 2S .
TABLE II
Binding of RA to Cytosolic Extracts of PCC4(RA)- 1 Cells after
Treatment with RA, Sodium Butyrate, or Both"
FIGURE 7 Acid-urea polyacryl-
amide gel analysis of histone sub-
species from 6050AJ and PCC4-
(RA)- 1 EC cells . Histories were
isolated as described in Materials
and Methods and 30 ug protein/
lane were electrophoresed for 16
hat200Vona14x18x0 .15
cm slab gel . (A) 6050AJ cells were
exposed to effectors for 5 d . Lane
1, control cells ; lane 2, 1 mM so-
dium butyrate; lane 3, 10-6M RA;
and lane 4, 3 mM HMBA . (B)
PCC4(RA)- 1 cells were exposed
to effectors for 7 d . Lane 1, con-
trol cells; lane 2, sodium butyrate
(1 mM for the first day, 3 mM
thereafter) ; lane 3,10-6M RA; and
lane 4, 3 mM HMBA.
* EC cells were cultured, cytosolic extracts were prepared, and binding
protein activity was assayed as described in Materials and Methods. RA
treatment was carried out at a concentration of 10 -6 M over 8 d . The cells
then were kept in control medium for 2 d to dilute out the added RA .
Sodium butyrate was used at a concentration of 1 mM for a period of 10 d .
the former cells but to a lesser degree in the latter. It has
already been observed that cRABP- mutants are relatively
unresponsive to inducers ofdifferentation otherthan retinoids
(25, 26) . Studies are in progress to determine why this is so .
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Cell line Treatment
cRABP levels
(fmol/mg protein)
PCC4.azaIR Control 493
RA 1,387
Sodium butyrate 754
PCC4(RA)- 1 Control 106
RA 81
Sodium butyrate 1,294
Sodium butyrate and RA 1,245REFERENCES
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